![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/12 | |
A61K 39/395 |
(11) | Number of the document | 3102599 |
(13) | Kind of document | T |
(96) | European patent application number | 14845032.3 |
Date of filing the European patent application | 2014-12-19 | |
(97) | Date of publication of the European application | 2016-12-14 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/078709 |
Date | 2014-12-19 |
(87) | Number | WO 2015/117711 |
Date | 2015-08-13 |
(30) | Number | Date | Country code |
14154158 | 2014-02-06 | EP | |
14166200 | 2014-04-28 | EP |
(72) |
NAGY, Eszter, AT
NAGY, Gįbor, HU
SZIJ RTO, Valeria, AT
GUACHALLA, Luis, AT
VASQUEZ, Maximiliano, US
|
(73) |
ARSANIS Biosciences GmbH,
Helmut-Qualtinger-Gasse 2, 1030 Vienna,
AT
|
(54) | E. COLI SPECIFIC ANTIBODY SEQUENCES |
E. COLI SPECIFIC ANTIBODY SEQUENCES |